SILO
Silo Pharma, Inc.
Latest Form 4:Purchase$2KbyWeisblum Eric (Chief Executive Officer) · filed Dec 16, 2025
Silo Pharma, Inc. (SILO) has 1 SEC Form 4 filing (2 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Dec 16, 2025.
- Industry:Biotechnology
- CEO:Eric Weisblum
- Employees:3
- HQ:Sarasota, FL, US
- IPO:2021-01-08
Insider Buying
$2K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
| Source | ||||||
|---|---|---|---|---|---|---|
Weisblum EricFirst filing | Chief Executive Officer | Purchase | 334 | $2K | Dec 16 | SEC ↗ |
Related companies
Silo Pharma, Inc. is in the Healthcare sector.